Charlotta Otter

1.1k total citations
16 papers, 893 citations indexed

About

Charlotta Otter is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Charlotta Otter has authored 16 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Charlotta Otter's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Charlotta Otter is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Charlotta Otter collaborates with scholars based in Sweden, United Kingdom and Germany. Charlotta Otter's co-authors include Magnus Ingelman‐Sundberg, Tommy B. Andersson, Mikael Oscarson, Brith Leidvik, Inger Johansson, Collen Masimirembwa, Eleni Aklillu, Mats Hidestrand, Anna L.V. Johansson and Robert J. Edwards and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Charlotta Otter

16 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotta Otter Sweden 12 659 391 274 98 95 16 893
Michael P. Pritchard United Kingdom 14 535 0.8× 250 0.6× 346 1.3× 52 0.5× 85 0.9× 18 812
Olaf Schaefer Japan 14 528 0.8× 515 1.3× 362 1.3× 160 1.6× 62 0.7× 16 1.1k
Sheryl G. Wood United States 22 614 0.9× 320 0.8× 265 1.0× 95 1.0× 58 0.6× 28 1.1k
Vsevolod E. Kostrubsky United States 19 619 0.9× 479 1.2× 213 0.8× 139 1.4× 47 0.5× 20 1.1k
B. Sinués Spain 16 464 0.7× 238 0.6× 309 1.1× 123 1.3× 74 0.8× 35 874
Catherine Spire France 12 370 0.6× 193 0.5× 341 1.2× 75 0.8× 60 0.6× 14 850
Harriet Gullstén Finland 8 517 0.8× 200 0.5× 327 1.2× 77 0.8× 69 0.7× 9 774
Summer Jolley United States 10 434 0.7× 272 0.7× 167 0.6× 97 1.0× 44 0.5× 11 825
Saki Yamano Japan 8 519 0.8× 288 0.7× 300 1.1× 111 1.1× 40 0.4× 23 844
David B. Buckley United States 17 499 0.8× 397 1.0× 420 1.5× 178 1.8× 62 0.7× 21 1.2k

Countries citing papers authored by Charlotta Otter

Since Specialization
Citations

This map shows the geographic impact of Charlotta Otter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Otter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Otter more than expected).

Fields of papers citing papers by Charlotta Otter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Otter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Otter. The network helps show where Charlotta Otter may publish in the future.

Co-authorship network of co-authors of Charlotta Otter

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Otter. A scholar is included among the top collaborators of Charlotta Otter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Otter. Charlotta Otter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Aklillu, Eleni, et al.. (2005). Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[a]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[a]pyrene. Cancer Research. 65(12). 5105–5111. 48 indexed citations
3.
Rodríguez‐Antona, Cristina, Magnus Axelson, Charlotta Otter, Anders Rane, & Magnus Ingelman‐Sundberg. (2005). A Novel Polymorphic Cytochrome P450 Formed by Splicing of CYP3A7 and the Pseudogene CYP3AP1. Journal of Biological Chemistry. 280(31). 28324–28331. 21 indexed citations
4.
Johansson, Anna L.V., Charlotta Otter, Tommy B. Andersson, et al.. (2003). COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM. Drug Metabolism and Disposition. 31(6). 755–761. 201 indexed citations
5.
Bapiro, Tashinga E., Tommy B. Andersson, Charlotta Otter, Julia A. Hasler, & Collen Masimirembwa. (2002). Cytochrome P 450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. European Journal of Clinical Pharmacology. 58(8). 537–542. 24 indexed citations
6.
Aklillu, Eleni, Mikael Oscarson, Mats Hidestrand, et al.. (2002). Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population. Molecular Pharmacology. 61(3). 586–594. 110 indexed citations
7.
Aklillu, Eleni, Mikael Oscarson, Mats Hidestrand, et al.. (2002). Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population. Molecular Pharmacology. 61(3). 586–594. 6 indexed citations
8.
Engman, Helena, Hans Lennernäs, Jan Taipalensuu, et al.. (2001). CYP3A4, CYP3A5, and MDR1 in Human Small and Large Intestinal Cell Llines Suitable for Drug Transport Studies. Journal of Pharmaceutical Sciences. 90(11). 1736–1751. 54 indexed citations
9.
Jahn, Thomas P., Jens Dietrich, Birgitte Andersen, et al.. (2001). Large scale expression, purification and 2D crystallization of recombinant plant plasma membrane H+-ATPase. Journal of Molecular Biology. 309(2). 465–476. 21 indexed citations
10.
Johansson, Inger, et al.. (2001). Cloning and Tissue Distribution of a Novel Human Cytochrome P450 of the CYP3A Subfamily, CYP3A43. Biochemical and Biophysical Research Communications. 281(5). 1349–1355. 146 indexed citations
11.
Ridderström, Marianne, et al.. (2000). Arginines 97 and 108 in CYP2C9 Are Important Determinants of the Catalytic Function. Biochemical and Biophysical Research Communications. 270(3). 983–987. 53 indexed citations
12.
McLellan, Roman A., Mikael Oscarson, Mats Hidestrand, et al.. (2000). Characterization and Functional Analysis of Two Common Human Cytochrome P450 1B1 Variants. Archives of Biochemistry and Biophysics. 378(1). 175–181. 46 indexed citations
13.
Masimirembwa, Collen, Charlotta Otter, Mikael Berg, et al.. (1999). Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research. Drug Metabolism and Disposition. 27(10). 1117–1122. 92 indexed citations
14.
Hansson, Lennart, Pia Wallbrandt, Mona Byström, et al.. (1995). Carbohydrate specificity of theEscherichia coli P-pilus papG protein is mediated by its N-terminal part. Biochimica et Biophysica Acta (BBA) - General Subjects. 1244(2-3). 377–383. 6 indexed citations
15.
Otter, Charlotta, Johan Edqvist, & Kerstin B. Stråby. (1992). Characterization of transcription and processing from plasmids that use polIII and a yeast tRNA gene as promoter to transcribe promoterdeficient downstream DNA. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1131(1). 62–68. 4 indexed citations
16.
Otter, Charlotta & Kerstin B. Stråby. (1991). Transcription of eukaryotic genes with impaired internal promoters: the use of a yeast tRNA gene as promoter. Journal of Biotechnology. 21(3). 289–293. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael P. Pritchard Breakdown of academic impact, for papers by Olaf Schaefer Breakdown of academic impact, for papers by Sheryl G. Wood Breakdown of academic impact, for papers by Vsevolod E. Kostrubsky Breakdown of academic impact, for papers by B. Sinués Breakdown of academic impact, for papers by Catherine Spire Breakdown of academic impact, for papers by Harriet Gullstén Breakdown of academic impact, for papers by Summer Jolley Breakdown of academic impact, for papers by Saki Yamano Breakdown of academic impact, for papers by David B. Buckley
Rankless by CCL
2026